Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $1.27B invested in Travere Therapeutics in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 41 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
-5
Holders Change %
-2.89%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
26
Increased
83
Reduced
41
Closed
30
Calls
$1.9M
Puts
$9.74M
Net Calls
-$7.84M
Net Calls Change
-$6.31M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$27.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$21M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$18.8M |
| 4 |
BlackRock
New York
|
+$16.4M |
| 5 |
Walleye Capital
New York
|
+$10.6M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$92.5M |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$28.4M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$22.2M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$14.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13.5M |
